 |
PDBsum entry 1w2g
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The crystal structure of mycobacterium tuberculosis thymidylate kinase in complex with 3'-Azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition.
|
 |
|
Authors
|
 |
E.Fioravanti,
V.Adam,
H.Munier-Lehmann,
D.Bourgeois.
|
 |
|
Ref.
|
 |
Biochemistry, 2005,
44,
130-137.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Tuberculosis (TB) is the primary cause of mortality among infectious diseases.
Mycobacterium tuberculosis thymidylate kinase (TMPK(Mtub)) catalyzes the
ATP-dependent phosphorylation of deoxythymidine 5'-monophosphate (dTMP).
Essential to DNA replication, this enzyme represents a promising target for
developing new drugs against TB, because the configuration of its active site is
unique within the TMPK family. Indeed, it has been proposed that, as opposed to
other TMPKs, catalysis by TMPK(Mtub) necessitates the transient binding of a
magnesium ion coordinating the phosphate acceptor. Moreover,
3'-azidodeoxythymidine monophosphate (AZTMP) is a competitive inhibitor of
TMPK(Mtub), whereas it is a substrate for human and other TMPKs. Here, the
crystal structures of TMPK(Mtub) in complex with deoxythymidine (dT) and AZTMP
were determined to 2.1 and 2.0 A resolution, respectively, and suggest a
mechanism for inhibition. The azido group of AZTMP perturbs the induced-fit
mechanism normally adopted by the enzyme. Magnesium is prevented from binding,
and the resulting electrostatic environment precludes phosphoryl transfer from
occurring. Our data provide a model for drug development against tuberculosis.
|
 |
|
|
|
|
 |